Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Endocrine reviews

• Publication date

  2012-10-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/er.2011-1034PMID 23065822PMCID PMC5393155
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polycystic Ovary Syndrome Is a Risk Factor for Type 2 Diabetes

  2012cited by this paper
• Is PCOS an inflammatory process?

  2012cited by this paper
• Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome.

  2012cited by this paper
• Cardiometabolic aspects of the polycystic ovary syndrome.

  2012cited by this paper
• Association of Fibrillin-3 and Transcription Factor-7-like 2 Gene Variants with Metabolic Phenotypes in PCOS

  2012cited by this paper
• Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry.

  2012cited by this paper
• Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.

  2012cited by this paper
• Hyperinsulinemia amplifies GnRH agonist stimulated ovarian steroid secretion in women with polycystic ovary syndrome.

  2012cited by this paper
• Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts

  2011cited by this paper
• Hemoglobin A1c as a tool for the diagnosis of type 2 diabetes in 208 premenopausal women with polycystic ovary syndrome.

  2011cited by this paper
• Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome.

  2011cited by this paper
• Tissue-specificity of insulin action and resistance*

  2011cited by this paper
• Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance.

  2011cited by this paper
• Intact primary mitochondrial function in myotubes established from women with PCOS.

  2011cited by this paper
• Racial influence on the polycystic ovary syndrome phenotype: a black and white case-control study.

  2011cited by this paper
• Bayesian inference of ancient human demography from individual genome sequences

  2011cited by this paper
• Racial Influence on the Polycystic Ovary Syndrome Phenotype: A Black White Case-Control Study

  2011cited by this paper
• Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3

  2011cited by this paper
• Genetic syndromes of severe insulin resistance.

  2011cited by this paper
• Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic.

  2011cited by this paper
• Clinically useful predictors of conversion to abnormal glucose tolerance in women with polycystic ovary syndrome.

  2011cited by this paper
• Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome.

  2011cited by this paper
• Inference of human population history from individual whole-genome sequences.

  2011cited by this paper
• Diagnosis and Classification of Diabetes Mellitus

  2011cited by this paper
• Linkage of regulators of TGF‐β activity in the fetal ovary to polycystic ovary syndrome

  2011cited by this paper
• IVF outcome in women with PCOS, PCO and normal ovarian morphology.

  2010cited by this paper
• Variants at DGKB/TMEM195, ADRA2A, GLIS3 and C2CD4B loci are associated with reduced glucose-stimulated beta cell function in middle-aged Danish people

  2010cited by this paper
• Molecular Mechanism of Insulin Resistance in Obesity and Type 2 Diabetes

  2010cited by this paper
• Standardization of testosterone measurements in humans.

  2010cited by this paper
• Prenatal androgen treatment alters body composition and glucose homeostasis in male rats.

  2010cited by this paper
• Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels.

  2010cited by this paper
• Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives.

  2010cited by this paper
• The determinants of insulin sensitivity, β-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome than in women who do not have hyperandrogenism.

  2010cited by this paper
• Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.

  2010cited by this paper
• Whole genome association studies in complex diseases: where do we stand?

  2010cited by this paper
• Androgen Excess Produces Systemic Oxidative Stress and Predisposes to β-Cell Failure in Female Mice

  2010cited by this paper
• Uncovering the roles of rare variants in common disease through whole-genome sequencing

  2010cited by this paper
• Menstrual cycle characteristics and risk of coronary heart disease and type 2 diabetes.

  2010cited by this paper
• Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.

  2010cited by this paper
• Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels

  2010cited by this paper
• Pathogenesis of Fasting and Postprandial Hyperglycemia in Type 2 Diabetes: Implications for Therapy

  2010cited by this paper
• Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications

  2010cited by this paper
• Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism.

  2010cited by this paper
• Diagnosis and Classification of Diabetes Mellitus

  2010cited by this paper
• Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?

  2010cited by this paper
• Insulin signaling meets mitochondria in metabolism.

  2010cited by this paper
• Myostatin (GDF-8) as a key factor linking muscle mass and bone structure.

  2010cited by this paper
• The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance.

  2010cited by this paper
• Rescue of obesity-induced infertility in female mice due to a pituitary-specific knockout of the insulin receptor.

  2010cited by this paper
• Insulin Resistance Is Not Conserved in Myotubes Established from Women with PCOS

  2010cited by this paper
• High prevalence of polycystic ovary syndrome in women born small for gestational age.

  2010cited by this paper
• Fibrillins in Adult Human Ovary and Polycystic Ovary Syndrome: Is Fibrillin-3 Affected in PCOS?

  2010cited by this paper
• The effect of insulin signaling on female reproductive function independent of adiposity and hyperglycemia.

  2010cited by this paper
• Genetic basis of polycystic ovary syndrome

  2010cited by this paper
• Disposition Index, Glucose Effectiveness, and Conversion to Type 2 Diabetes

  2010cited by this paper
• Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility.

  2010cited by this paper
• Family-based analysis of candidate genes for polycystic ovary syndrome.

  2010cited by this paper
• Polymorphisms of the insulin receptor and the insulin receptor substrates genes in polycystic ovary syndrome: a Mendelian randomization meta-analysis.

  2010cited by this paper
• A pathway that links reproductive status to lifespan in Caenorhabditis elegans

  2010cited by this paper
• Insulin resistance directly contributes to androgenic potential within ovarian theca cells.

  2009cited by this paper
• Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome.

  2009cited by this paper
• Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys

  2009cited by this paper
• The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study.

  2009cited by this paper
• Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population.

  2009cited by this paper
• Fetal programming of glucose-insulin metabolism.

  2009cited by this paper
• Genomewide association studies--illuminating biologic pathways.

  2009cited by this paper
• Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large‐scale Chinese population

  2009cited by this paper
• Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome.

  2009cited by this paper
• Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance.

  2009cited by this paper
• Finding the missing heritability of complex diseases

  2009cited by this paper
• Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.

  2009cited by this paper
• Common genetic variation and human traits.

  2009cited by this paper
• Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1/2 by insulin in skeletal muscle in vivo.

  2009cited by this paper
• Effect of Testosterone on Insulin Stimulated IRS1 Ser Phosphorylation in Primary Rat Myotubes—A Potential Model for PCOS-Related Insulin Resistance

  2009cited by this paper
• Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease.

  2009cited by this paper
• The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

  2009cited by this paper
• Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2.

  2009cited by this paper
• The Role of Insulin-Sensitizing Agents in the Treatment of Polycystic Ovary Syndrome

  2009cited by this paper
• Role of follistatin in promoting adipogenesis in women.

  2009cited by this paper
• Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review.

  2009cited by this paper
• Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.

  2009cited by this paper
• Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome.

  2009cited by this paper
• Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis.

  2009cited by this paper
• Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries

  2009cited by this paper
• Sex differences in the regulation of body weight.

  2009cited by this paper
• Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease

  2009cited by this paper
• Metabolic parameters in cord blood of newborns of women with polycystic ovary syndrome.

  2009cited by this paper
• Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria.

  2008cited by this paper
• Follicle dynamics and anovulation in polycystic ovary syndrome.

  2008cited by this paper
• Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes

  2008cited by this paper
• A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system.

  2008cited by this paper
• Genome-wide association studies for complex traits: consensus, uncertainty and challenges

  2008cited by this paper
• Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome.

  2008cited by this paper
• Incretin levels in polycystic ovary syndrome.

  2008cited by this paper
• Transient prenatal androgen exposure produces metabolic syndrome in adult female rats.

  2008cited by this paper
• Impaired Insulin-Stimulated Phosphorylation of Akt and AS160 in Skeletal Muscle of Women With Polycystic Ovary Syndrome Is Reversed by Pioglitazone Treatment

  2008cited by this paper
• Endocrine Antecedents of Polycystic Ovary Syndrome in Fetal and Infant Prenatally Androgenized Female Rhesus Monkeys1

  2008cited by this paper
• Fasting insulin pulsatile secretion in lean women with polycystic ovary syndrome.

  2008cited by this paper
• Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.

  2008cited by this paper
• Evidence for insulin suppression of baseline luteinizing hormone in women with polycystic ovarian syndrome and normal women.

  2008cited by this paper

• Metabolic Messengers: testosterone

  2026cites this paper
• Therapeutic mechanisms of metformin and Bushen Ditan Decoction in polycystic ovary syndrome: Evidence from a rat model and miRNA sequencing

  2026cites this paper
• NMN/NAD+/SIRT1 axis activates NAMPT to ameliorate H2O2-triggered the impairment of progesterone synthesis in ovarian granulosa cells.

  2026cites this paper
• Endometrial receptivity in polycystic ovary syndrome: altered biomarkers and underlying mechanisms.

  2026cites this paper
• Beyond Monotherapy: Targeting the triad of insulin resistance, hyperandrogenism and obesity in PCOS.

  2026cites this paper
• The Combinatory Effect of Salvia officinalis and Nigella sativa Extracts on Polycystic Ovarian Syndrome Induced in Mice

  2026cites this paper
• The pathogenesis, therapeutic targets and drugs of polycystic ovary syndrome

  2026cites this paper
• Research on the Mechanism of β-Sitosterol in Improving Polycystic Ovary Syndrome by Regulating CYP17A1/CYP19A1 Expression

  2026cites this paper
• Yoga as a therapeutic modality for hormonal and metabolic regulation in premenopausal women with polycystic ovary syndrome

  2026cites this paper
• Effect on insulin clearance of different pharmacological treatments in women with polycystic ovary syndrome: a hypothesis-generative study.

  2026cites this paper
• Relationship between hypothalamic-pituitary-adrenal axis activity and menstrual irregularities in women with polycystic ovary syndrome.

  2026cites this paper
• Restoring Homeodynamics: Autophagy, Ageing and the Metabolic Correction of Disease

  2026cites this paper
• Increased DNA and oxidative damage in PCOS: effect of elevated androgens

  2026cites this paper
• Therapeutic potential of umbilical cord-derived mesenchymal stem/stromal cells versus their conditioned media on treatment of polycystic ovary In-vivo.

  2026cites this paper
• Polycystic ovary syndrome in women with bipolar affective disorder or epilepsy exposed to valproic acid: a nationwide 16-year cohort study

  2026cites this paper
• Insulin Resistance: Implications for Nutrition, Oncology, and Diabetes Management-An Updated Review

  2026cites this paper
• Manejo integral del síndrome de ovario poliquístico: revisión sistemática de estrategias terapéuticas farmacológicas

  2026cites this paper
• Vitamin D Deficiency and Polycystic Ovary Syndrome: Molecular Mechanisms and Siddha-Based Integrative Therapeutic Insights

  2026cites this paper
• Cross-talking between polycystic ovarian syndrome and gut microbiome: a comprehensive review

  2026cites this paper
• Changes in Menstrual Regularity and Associated Factors in Women With Obesity Without PCOS Following Bariatric Surgery.

  2026cites this paper
• Hormonal and metabolic profiles in teenagers and young adults with polycystic ovary syndrome (PCOS)

  2026cites this paper
• Efficacy of liraglutide on metabolic and reproductive outcomes in women with polycystic ovary syndrome: A systematic review and meta-analysis.

  2026cites this paper
• Harnessing probiotic-metformin synergy: targeting the gut-microbiota metabolism axis to ameliorate polycystic ovary syndrome

  2026cites this paper
• Insulin resistance and coronary microvascular dysfunction: a complex interplay

  2026cites this paper
• Divergent pathophysiological drivers of polycystic ovary syndrome: insulin resistance independently fuels the hyperandrogenic phenotype whilst neuroendocrine factors dominate non-hyperandrogenic presentations.

  2026cites this paper
• BMI-stratified phenotypes of polycystic ovary syndrome: advances in gut microbiota research and personalized management strategies.

  2026cites this paper
• Efficacy and safety of acupuncture-related therapies in improving insulin resistance, reproductive endocrine outcomes, and ovarian morphology in polycystic ovary syndrome: a systematic review and network meta-analysis

  2026cites this paper
• Therapeutic potential of Glycyrrhiza glabra (licorice) in modulating metabolic and inflammatory parameters in women with PCOS

  2026cites this paper
• Evolving PCOS Management: From Symptom Control to Phenotype-Targeted Therapy

  2026cites this paper
• Associations Between Prepregnancy Menstrual Characteristics, Age at Menarche, and the Risk of Gestational Diabetes Mellitus: A Matched Case–Control Study

  2026cites this paper
• Dose-response of acupuncture on ovulation rates in polycystic ovary syndrome: a meta-analysis and exploratory dose-response analysis

  2025influential citation
• Oral glucose tolerance test-induced increases in femoral blood flow are absent in non-obese females with polycystic ovary syndrome.

  2025cites this paper
• Pharmacotherapeutic Role of Ketohexokinase in Metabolic Disorders and PCOS: A Systematic Review

  2025cites this paper
• Gene regulatory activity associated with polycystic ovary syndrome revealed DENND1A-dependent testosterone production

  2025influential citation
• Cardiovascular Consequences of Premature Menopause

  2025cites this paper
• Exploring the interactions of gut microbiome and metabolites in polycystic ovary syndrome: a review.

  2025cites this paper
• Association of serum creatinine/cystatin C ratio with insulin resistance and all-cause mortality: a national cohort analysis

  2025cites this paper
• Gestörte Metabolik und kardiovaskuläres Risiko am Beispiel des polyzystischen Ovarialsyndroms (PCOS)

  2025cites this paper
• Association between surrogate markers of insulin resistance and gastric cancer risk in South Korea: A nationwide population-based study

  2025cites this paper
• Mechanisms of traditional Chinese medicine regulating polycystic ovary syndrome through gut microbiota: a review

  2025cites this paper
• Phytotherapy in Polycystic Ovary Syndrome (PCOS) Management: A Systematic Review

  2025cites this paper
• Association of Organochlorine Pesticide Exposure as Endocrine Disruptors with Polycystic Ovarian Syndrome in North India

  2025cites this paper
• Metabolic phenotype in non-aldosterone producing adrenal adenomas with co-existent polycystic ovary syndrome: a joint Ens@t project

  2025cites this paper
• Metabolic Mediation of the Association Between Hyperandrogenism and Paratubal Cysts in Polycystic Ovary Syndrome: A Structural Equation Modeling Approach

  2025cites this paper
• Genetics of Polycystic Ovary Syndrome (PCOS).

  2025cites this paper
• Treatment Options for Managing Anovulation in Women with PCOS: An Extensive Literature Review of Evidence-Based Recommendations for Future Directions

  2025cites this paper
• Isatin ameliorates ovarian inflammation and apoptosis caused by hormonal imbalances in PCOS mice.

  2025cites this paper
• Effects of individualized exercise on body composition, lipid profile, mental health, and ovarian cysts in a young woman with polycystic ovarian syndrome – case study

  2025cites this paper
• Relations of Insulin Resistance, Body Weight, Vitamin D Deficiency, SHBG and Androgen Levels in PCOS Patients

  2025cites this paper
• Endocrine traits during pregnancy in women with polycystic ovary syndrome - insights from a prospective cohort study in China

  2025cites this paper
• Genetic and hormonal insights into PCOS: Role of FSHR rs6166 and LHCGR rs2293275 polymorphisms

  2025cites this paper
• Experimental analysis of acupuncture's effects on hyperandrogenemia and related symptoms in PCOS patients

  2025cites this paper
• Polygenic risk scores of fasting insulin and insulin-related traits in a Taiwanese Han population

  2025cites this paper
• Regulation of oxytocin receptor by zinc coumarin derivatives: a mechanistic approach to alleviate anxiety and enhance folliculogenesis in letrozole-induced PCOS in zebrafish model

  2025cites this paper
• PCOS and the Genome: Is the Genetic Puzzle Still Worth Solving?

  2025cites this paper
• Reproductive prognosis factors in women with infertility and polycystic ovary syndrome undergoing in vitro fertilization techniques

  2025cites this paper
• Pathogenic variation in insulin resistance genes is common in polycystic ovary syndrome (PCOS): a strategy for causal gene discovery using whole-exome sequencing (WES) in complex traits

  2025cites this paper
• Metabolic Risk Profile of Eastern Indian Women with Different Phenotypes of Polycystic Ovary Syndrome

  2025cites this paper
• The Hypothalamic Nuclei Implicated in the Regulation of Polycystic Ovary Syndrome: A Review of Its Clinical, Metabolic, and Endocrine Aspects

  2025cites this paper
• A Pilot Randomized Control Trial Evaluating the Feasibility of a 12-Week Mediterranean Diet Intervention Without Caloric Restriction in Women with Polycystic Ovary Syndrome

  2025cites this paper
• Insulin Resistance in PCOS: Pathophysiological Mechanisms of Menstrual Dysfunction and Evidence-Based Treatment Strategies.

  2025cites this paper
• Protective Effect of Marjoram Against Letrozole-Induced Ovarian Damage in Rats with Polycystic Ovarian Syndrome Entails Activation of Nrf2 and Suppression of NF-κB

  2025cites this paper
• Network pharmacology and experimental validation to elucidate the mechanism of the treatment of polycystic ovary syndrome with insulin resistance by Resina Draconis

  2025cites this paper
• Proteomic Study Between Interstitial Channels Along Meridians and Adjacent Areas in Mini-Pigs

  2025cites this paper
• Unveiling lipoprotein subfractions signature in high-FNPO PCOS: implications for PCOM diagnosis and risk assessment using advanced machine learning models

  2025cites this paper
• Sleep disorders and psychological comorbidities in women with polycystic ovary syndrome – a cross-sectional study

  2025cites this paper
• Cardiovascular disease in women with type 1 diabetes: a narrative review and insights from a population-based cohort analysis

  2025cites this paper
• Síndrome dos ovários policísticos com amenorreia primária: uma série de casos

  2025cites this paper
• Nutritional and herbal interventions for polycystic ovary syndrome (PCOS): a comprehensive review of dietary approaches, macronutrient impact, and herbal medicine in management

  2025cites this paper
• Interface between reproductive and metabolic dysfunction in polycystic ovary syndrome.

  2025cites this paper
• Transcriptome analysis of early embryonic development in a mouse model of polycystic ovary syndrome

  2025cites this paper
• Sexual Dysfunctions in Chronic Liver Diseases: A Narrative Review on Prevalence and Putative Pathophysiologic Mechanisms.

  2025cites this paper
• The Role of Aromatic Amino Acids in Polycystic Ovary Syndrome through Patients’ Blood Metabolic Profiling: A Systematic Review of the Past Five Years

  2025cites this paper
• Dingkun Pill-Mediated TGF-β1/Smad2 Pathway Effects on Granulosa Cell Proliferation and Apoptosis.

  2025cites this paper
• Psychiatric disorders, impulsivity and borderline personality in patients with polycystic ovary syndrome

  2025cites this paper
• Recognizing the Role of Insulin Resistance in Polycystic Ovary Syndrome: A Paradigm Shift from a Glucose-Centric Approach to an Insulin-Centric Model

  2025cites this paper
• Prevalence of subclinical hypothyroidism in polycystic ovary syndrome and its impact on insulin resistance: a systematic review and meta-analysis

  2025cites this paper
• Evaluating Spironolactone Monotherapy Against Combined Treatment with Metformin in Rat PCOS Model.

  2025cites this paper
• Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis

  2025cites this paper
• The Anti-Mullerian Hormone as a Biomarker of Effectiveness of Metformin Hydrochloride Therapy in Polycystic Ovarian Syndrome and Insulin Resistance

  2025cites this paper
• Unraveling the Complexity of Polycystic Ovary Syndrome (PCOS): A Comprehensive Review

  2025cites this paper
• The association between serum growth differentiation factor 15 and insulin resistance in women diagnosed with polycystic ovary syndrome

  2025cites this paper
• Gingival Inflammation Modulates NLRP3 Inflammasome Signalling in Peripheral Blood Mononuclear Cells of PCOS Patients: A Case-Control Study

  2025cites this paper
• Understanding Polycystic Ovarian Syndrome and Its Association with Menstrual Dysfunction and Body Fat Distribution: A Comparative Study

  2025cites this paper
• Blood biochemical landscape and new insights into clinical decision-making for polycystic ovary syndrome in Chinese women: a prospective cohort study

  2025cites this paper
• The Role of Curcumin in Polycystic Ovary Syndrome (PCOS): Evidence and Mechanisms

  2025cites this paper
• Unraveling the Connection between PCOS and renal Complications: Current insights and Future Directions.

  2025cites this paper
• Global Burden of type 2 diabetes in non-elderly individuals 1990 to 2021 and projections for 2050: a systematic analysis of the 2021 Global Burden of Disease.

  2025cites this paper
• Evaluating indices of insulin resistance and estimating the prevalence of insulin resistance in a large biobank cohort

  2025cites this paper
• Pachymic acid ameliorates polycystic ovary syndrome via inactivating Akt/ERK signaling.

  2025cites this paper
• Chemically-induced histopathological progression in the polycystic ovary syndrome (PCOS)- A review

  2025cites this paper
• Adiponectin: its role in diabetic and pancreatic cancer.

  2025cites this paper
• Extracellular fluid miRNAs in PCOS.

  2025cites this paper
• Ovarian Hyperthecosis Presenting With Postmenopausal Virilization and New-Onset Type 2 Diabetes

  2025cites this paper
• Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome

  2025cites this paper
• Interaction between interleukin 10 (IL-10) gene polymorphisms and obesity on susceptibility to polycystic ovary syndrome in Chinese women

  2025cites this paper
• The Ontogeny of Distinct Reproductive Phenotypes in Girls at Risk for PCOS During the Postmenarchal Transition.

  2025cites this paper
• Role of Granulosa Cell Dysfunction in Women Infertility Associated with Polycystic Ovary Syndrome and Obesity

  2025cites this paper
• Impact of Hypocaloric Dietary Intervention on Phenotypic Presentations of Polycystic Ovary Syndrome (PCOS)

  2025cites this paper
• Unraveling the gut microbiota’s role in PCOS: a new frontier in metabolic health

  2025cites this paper